// App-Quantinova.ai

e23094 : Modelization of the procoagulant properties of cancer cells and the alterations of the effectiveness of the anticoagulant agents.

Researchers

Presenter

  • Aurelie Rousseau

Principal Investigators

  • Patrick Van Dreden

  • Elisabeth Mbemba

  • Annette K. Larsen

  • Hayat Mokrani

  • Ismail Elalamy

  • Konstantinos N. Syrigos

  • Grigoris Gerotziafas

Medical Centers

  • Clinical Research Department, Diagnostica Stago, Gennevilliers, France

  • Service d'Hematologie Biologique Hopital Tenon , APHP Paris, France, Paris, France

  • Cancer Biology and Therapeutics and Universite Pierre et Marie Curie, Paris, France

  • 1 INSERM U938, Faculte de Medecine Pierre et Marie Curie, Universite Paris VI, Paris, France

  • Department of Haematology, Tenon University Hospital, Assistance Publique Hopitaux de Paris, Paris, France

  • Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece

Locations

  • France

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Catalase

Drug/Treatment

  • Fondaparinux sodium

  • Enoxaparin

  • Enoxaparin sodium

  • apixaban

  • Trypsin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved